The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Asiafocus Regulatory News (AAS)

Share Price Information for Abrdn Asiafocus (AAS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 279.00
Bid: 278.00
Ask: 280.00
Change: 4.00 (1.45%)
Spread: 2.00 (0.719%)
Open: 279.00
High: 279.00
Low: 279.00
Prev. Close: 275.00
AAS Live PriceLast checked at -
abrdn Asia Focus is an Investment Trust

To maximise long-term total return from a portfolio made up predominantly of smaller quoted companies (with a market cap of up to approximately USD 1.5bn at the time of investment) in the economies of Asia and Australasia, ex Japan.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Update

3 Jun 2020 11:31

RNS Number : 8331O
Aberdeen Standard Asia Focus PLC
03 June 2020
 

ABERDEEN STANDARD ASIA FOCUS PLC (the "Company")

Legal Entity Identifier (LEI): 5493000FBZP1J92OQY70

 

3 June 2020

 

Directorate Update

 

Appointment of Krishna Shanmuganathan and Retirement of Philip Yea

 

The Board of Aberdeen Standard Asia Focus PLC is pleased to announce the appointment of Mr Krishna Shanmuganathan as an independent non-executive Director of the Company with effect from 3 June 2020.

 

Nigel Cayzer, Chairman, commented:

 

"On behalf of the Board I am delighted to welcome Krish to the Board. Krish brings significant strategic, Asia-focused experience to the Board. He founded Scylax Partners in 2016 and prior to that was managing partner at Hakluyt & Company (Asia), a risk advisory company, having established and led the Asia Pacific offices of the firm, based in Singapore. Before that Krish held research and analyst roles at Fidelity International and Cambridge Associates after a successful and varied career in the Foreign & Commonwealth Office. He holds a number of other non-executive appointments including being on the advisory board of Serendipity Capital, chairman of the trustees of St Jude India ChildCare Centres UK and a trustee of Solefield School Educational Trust.

 

Following his recent appointment as Chairman of Mondi plc, and after six years on the Board, Philip Yea has decided to retire from the Company's Board at the next Annual General Meeting, to be held in December 2020. I would like to take this opportunity to thank him very much, on behalf of both the Board and shareholders, for his significant contribution as a Director since his appointment in 2014 and latterly for his expert guidance as Audit Committee Chairman.

 

With effect from the conclusion of the December 2020 Annual General Meeting Ms Debby Guthrie will become Chair of the Audit Committee."

 

In accordance with Listing Rule 9.6.13 (1):

 

Mr Shanmuganathan is not currently a director of any publicly listed companies and has not in the last five years been a director of any publicly listed companies.

 

Mr Shanmuganathan does not have a beneficial interest in any Ordinary shares of the Company.

 

In relation to Mr Shanmuganathan's appointment, there is no additional information required to be disclosed in accordance with Listing Rules 9.6.13 (2) - (6).

 

For further information, please contact:

 

Charles Mearns

Aberdeen Asset Management PLC

Secretaries

Tel. 0131 528 4132

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUUWQUPUGUW
Date   Source Headline
3rd May 20244:40 pmRNSQuarterly disclosure
3rd May 202412:54 pmRNSNet Asset Value(s)
2nd May 202412:59 pmRNSNet Asset Value(s)
1st May 202410:45 amRNSTotal Voting Rights
30th Apr 202412:55 pmRNSNet Asset Value(s)
30th Apr 202411:20 amRNSGearing disclosure
29th Apr 202412:38 pmRNSNet Asset Value(s)
26th Apr 20245:23 pmRNSTransaction in Own Shares
26th Apr 202412:45 pmRNSNet Asset Value(s)
25th Apr 20241:27 pmRNSNet Asset Value(s)
24th Apr 20245:41 pmRNSTransaction in Own Shares
24th Apr 20245:07 pmRNSCULS Interest Payment Date
24th Apr 20245:06 pmRNSCULS Conversion Notice
24th Apr 202412:11 pmRNSNet Asset Value(s)
23rd Apr 20245:15 pmRNSTransaction in Own Shares
23rd Apr 202412:47 pmRNSNet Asset Value(s)
22nd Apr 20242:04 pmRNSGearing disclosure
22nd Apr 202412:21 pmRNSNet Asset Value(s)
19th Apr 202412:46 pmRNSNet Asset Value(s)
18th Apr 20245:08 pmRNSTransaction in Own Shares
18th Apr 20243:44 pmRNSHolding(s) in Company
18th Apr 202412:36 pmRNSNet Asset Value(s)
17th Apr 20245:20 pmRNSTransaction in Own Shares
17th Apr 202412:08 pmRNSNet Asset Value(s)
16th Apr 20241:00 pmRNSNet Asset Value(s)
15th Apr 20245:43 pmRNSPortfolio Disclosures
15th Apr 20243:27 pmRNSGearing Disclosures
15th Apr 202412:48 pmRNSNet Asset Value(s)
12th Apr 202412:56 pmRNSNet Asset Value(s)
12th Apr 202412:38 pmRNSDoc re. Half Yearly Report
11th Apr 202412:42 pmRNSNet Asset Value(s)
10th Apr 20245:21 pmRNSTransaction in Own Shares
10th Apr 202412:53 pmRNSNet Asset Value(s)
9th Apr 202411:59 amRNSNet Asset Value(s)
8th Apr 20245:17 pmRNSTransaction in Own Shares
8th Apr 20242:46 pmRNSGearing disclosure
8th Apr 20241:00 pmRNSNet Asset Value(s)
5th Apr 202412:33 pmRNSNet Asset Value(s)
4th Apr 202412:47 pmRNSNet Asset Value(s)
3rd Apr 20244:38 pmRNSHolding(s) in Company
3rd Apr 202412:47 pmRNSNet Asset Value(s)
2nd Apr 20243:33 pmRNSGearing disclosure
2nd Apr 202410:56 amRNSHolding(s) in Company
2nd Apr 202410:17 amRNSTotal Voting Rights
28th Mar 20242:04 pmRNSNet Asset Value(s)
28th Mar 20247:00 amRNSHalf-year Report
27th Mar 20244:04 pmRNSHolding(s) in Company
27th Mar 202412:19 pmRNSNet Asset Value(s)
26th Mar 202412:24 pmRNSNet Asset Value(s)
25th Mar 20243:58 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.